Cargando…

Modifiable Risk Factors for Cardiovascular Disease in Children with Type 1 Diabetes: Can Early Intervention Prevent Future Cardiovascular Events?

PURPOSE OF REVIEW: Patients with type 1 diabetes have increased risk for cardiovascular disease. The purpose of this review is to examine the following: i).. current evidence for subclinical cardiovascular disease (CVD) in children with type 1 diabetes (T1DM); ii).. known modifiable risk factors for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gourgari, Evgenia, Dabelea, Dana, Rother, Kristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Macrovascular Complications in Diabetes (VR Aroda and A Getaneh, Section Editors)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670186/ https://www.ncbi.nlm.nih.gov/pubmed/29101482 http://dx.doi.org/10.1007/s11892-017-0968-y

Ejemplares similares

Effect of Health Information Technologies on Cardiovascular Risk Factors among Patients with Diabetes
por: Yoshida, Yilin, et al.
Publicado: (2019)

Cardiovascular and Mortality Risks in Migrant South Asians with Type 2 Diabetes: Are We Winning the Battle?
por: Johns, Emma, et al.
Publicado: (2017)

Revisiting the Diabetes-Heart Failure Connection
por: Wallner, Markus, et al.
Publicado: (2018)

The Road to Approval: a Perspective on the Role of Icosapent Ethyl in Cardiovascular Risk Reduction
por: Wang, Xiaowen, et al.
Publicado: (2020)

Do Women with Diabetes Need More Intensive Action for Cardiovascular Reduction than Men with Diabetes?
por: Harreiter, Jürgen, et al.
Publicado: (2020)

What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020)

Regulating Polyamine Metabolism by miRNAs in Diabetic Cardiomyopathy
por: Kambis, Tyler N., et al.
Publicado: (2021)

COVID-19 and Diabetes Outcomes: Rationale for and Updates from the CORONADO Study
por: Smati, Sarra, et al.
Publicado: (2022)

Social Determinants of Health, Race, and Diabetes Population Health Improvement: Black/African Americans as a Population Exemplar
por: Hill-Briggs, Felicia, et al.
Publicado: (2022)

Genetics of Type 2 Diabetes: Implications from Large-Scale Studies
por: DeForest, Natalie, et al.
Publicado: (2022)

Thinking Ahead to the Next Generation of Cardiometabolic Investigators: What It Takes to Successfully Engage Underrepresented Minorities in Biomedical and Public Health Careers
por: White, Wendy B., et al.
Publicado: (2022)

Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes
por: Wretlind, Asger, et al.
Publicado: (2023)

Cardiovascular Autonomic Neuropathy and Subclinical Cardiovascular Disease in Normoalbuminuric Type 1 Diabetic Patients
por: Mogensen, Ulrik Madvig, et al.
Publicado: (2012)

Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality
por: Selvin, Elizabeth, et al.
Publicado: (2016)

Baroreflex Sensitivity Impairment During Hypoglycemia: Implications for Cardiovascular Control
por: Rao, Ajay D., et al.
Publicado: (2016)

Glycemic Control and Cardiovascular Mortality in Hemodialysis Patients With Diabetes: A 6-Year Cohort Study
por: Ricks, Joni, et al.
Publicado: (2012)

Glycation of LDL by Methylglyoxal Increases Arterial Atherogenicity: A Possible Contributor to Increased Risk of Cardiovascular Disease in Diabetes
por: Rabbani, Naila, et al.
Publicado: (2011)

Serum Vascular Adhesion Protein-1 Predicts 10-Year Cardiovascular and Cancer Mortality in Individuals With Type 2 Diabetes
por: Li, Hung-Yuan, et al.
Publicado: (2011)

Higher frequency of cardiovascular autonomic neuropathy in youth with type 2 compared to type 1 diabetes: Role of cardiometabolic risk factors
por: Varley, Benjamin J., et al.
Publicado: (2022)

Relationship of Glycated Albumin to Blood Glucose and HbA(1c) Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study
por: Nathan, David M., et al.
Publicado: (2014)

Trends in Incidence of Type 1 Diabetes Among Non-Hispanic White Youth in the U.S., 2002–2009
por: Lawrence, Jean M., et al.
Publicado: (2014)

Too Much Glucagon, Too Little Insulin: Time course of pancreatic islet dysfunction in new-onset type 1 diabetes
por: Brown, Rebecca J., et al.
Publicado: (2008)

Differences in retinopathy prevalence and associated risk factors across 11 countries in three continents: A cross‐sectional study of 156,090 children and adolescents with type 1 diabetes
por: Bratina, Natasa, et al.
Publicado: (2022)

Higher Plasma Soluble Receptor for Advanced Glycation End Products (sRAGE) Levels Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: A 12-Year Follow-Up Study
por: Nin, Johanna W.M., et al.
Publicado: (2010)

Diabetes-Induced NF-κB Dysregulation in Skeletal Stem Cells Prevents Resolution of Inflammation
por: Ko, Kang I., et al.
Publicado: (2019)

Cardiovascular risk factors early in the course of treatment in people with type 2 diabetes without established cardiovascular disease: A population‐based observational retrospective cohort study
por: Khunti, Kamlesh, et al.
Publicado: (2021)

Bcl-2–Modifying Factor Induces Renal Proximal Tubular Cell Apoptosis in Diabetic Mice
por: Lau, Garnet J., et al.
Publicado: (2012)

Trends in High-Risk HLA Susceptibility Genes Among Colorado Youth With Type 1 Diabetes
por: Vehik, Kendra, et al.
Publicado: (2008)

Association Between Impaired Cardiovascular Autonomic Function and Hypoglycemia in Patients With Type 1 Diabetes
por: Jaiswal, Mamta, et al.
Publicado: (2014)

Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes
por: Bjerre-Christensen, Theis, et al.
Publicado: (2021)

Correlation of global risk assessment with cardiovascular complications in patients with diabetes mellitus living in Puerto Rico
por: Rodríguez-Vigil, Efraín, et al.
Publicado: (2016)

Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS
por: Koshino, Akihiko, et al.
Publicado: (2022)

Levels of Oxidized LDL and Advanced Glycation End Products–Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased Levels of Carotid Intima-Media Thickness and Its Progression in Type 1 Diabetes
por: Lopes-Virella, Maria F., et al.
Publicado: (2011)

Progression of Cardiovascular Autonomic Dysfunction in Patients With Type 2 Diabetes: A 7-year follow-up study
por: Ko, Seung-Hyun, et al.
Publicado: (2008)

Cardiovascular risk factors from diagnosis in children with type 1 diabetes mellitus: a longitudinal cohort study
por: Jones, Stephanie, et al.
Publicado: (2019)

Prospectively Determined Impact of Type 1 Diabetes on Brain Volume During Development
por: Perantie, Dana C., et al.
Publicado: (2011)

Montelukast Prevents Early Diabetic Retinopathy in Mice
por: Bapputty, Reena, et al.
Publicado: (2019)

CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes
por: Teng, Beina, et al.
Publicado: (2016)

FOXO1 Deletion Reverses the Effect of Diabetic-Induced Impaired Fracture Healing
por: Alharbi, Mohammed A., et al.
Publicado: (2018)

Foxo1 Inhibits Diabetic Mucosal Wound Healing but Enhances Healing of Normoglycemic Wounds
por: Xu, Fanxing, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sgp8uh2dgmajq9hben2620ssvg